Startups
Mobile solutions, cloud technology, and connected devices are converging to create a new Artificial Intelligence platform that optimizes Diabetes and Pre-Diabetes Management.
With scientists, statisticians, engineers, specialist healthcare professionals, and nutritionists on board, the company has built DIABNEXT®, the first Diabetes A.I. that enables unique personalized metric analysis and decision making tools for doctors and patients to better manage pre-diabetes and diabetes.
Based in Boston, Taipei, Hong Kong, and Bangalore, DIABNEXT® owns patents in Diabetes care, and won two CES Innovation Awards in the Biotech category with its “Bee Smart Diabetes Tracker” in 2015 and in 2017 for its latest innovation, CLIPSULIN®.
With scientists, statisticians, engineers, specialist healthcare professionals, and nutritionists on board, the company has built DIABNEXT®, the first Diabetes A.I. that enables unique personalized metric analysis and decision making tools for doctors and patients to better manage pre-diabetes and diabetes.
Based in Boston, Taipei, Hong Kong, and Bangalore, DIABNEXT® owns patents in Diabetes care, and won two CES Innovation Awards in the Biotech category with its “Bee Smart Diabetes Tracker” in 2015 and in 2017 for its latest innovation, CLIPSULIN®.
Overview
Employees
11-50
Founded date
2016
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Le Village by CA | levillagebyca.com |
Mentions in press and media 1
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
Reviews 0
FAQ about DIABNEXT
When was DIABNEXT founded?
DIABNEXT was founded in 2016.
Who has invested in DIABNEXT?
Parsers VC lists 2 investors of DIABNEXT, among them Le Village by CA.
Is DIABNEXT still active?
Yes, DIABNEXT is active; its latest activity on Parsers VC dates from Mar 16, 2022.